September/October 2013

People with chronic conditions need effective and affordable drugs to live longer and better lives. Unfortunately, regulations covering plans in state exchanges may impede access.

This review presents data on ipilimumab and vemurafenib, 2 new targeted agents recently approved for the treatment of metastatic melanoma.

The authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.

This article reviews current drug therapies for heart failure and therapy integration into a patient care framework improving patient adherence, quality of life, and decreased risk of readmission to acute care facilities.

This study reports on barriers to and facilitators of medication adherence for asthma and diabetes patients who were both adherent and nonadherent to their medication regimen.

To achieve the triple aim, the healthcare benefit and the pharmacy benefit must evolve.